Ex vivo evaluation of PBMNCs collected with a new cell separator

Transfusion

Volumn 41, Issue 7, 2001, Pages 940-949

  Snyder, Edward L ^a,b,c   O'Donnell, Lynn ^a,b   Dengler, Thomas J ^a,b   Pomper, Gregory J ^a,b   Velleca, Mark A ^a,b   Dincecco, Dorothy M ^a,b   Baril, Laurene L ^a,b   Min, Kyungyoon ^a,b   Gudino, Maria D ^a,b   Bender, Jeffrey R ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BAXTER HEALTHCARE CORPORATION   (United States)

^c YALE NEW HAVEN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; GROWTH FACTOR;

APHERESIS; ARTICLE; B LYMPHOCYTE; CELL SEPARATION; CELL SUBPOPULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; MONOCYTE; MONONUCLEAR CELL; NATURAL KILLER CELL; NORMAL HUMAN; T LYMPHOCYTE SUBPOPULATION;

BLOOD DONORS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIVISION; CELL SEPARATION; CYTOTOXICITY TESTS, IMMUNOLOGIC; E-SELECTIN; ENDOTHELIUM, VASCULAR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT, NEWBORN; KILLER CELLS, NATURAL; LEUKAPHERESIS; LEUKOCYTES, MONONUCLEAR; TIME FACTORS; UMBILICAL VEINS;

EID: 0034938339     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2001.41070940.x     Document Type: Article

References (32)

1. Dendritic cells and the control of immunity
2. Comparison of single-dose and escalating-dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemia
3. Donor lymphocyte infusions for relapse of chronic myeloid leukemia after allogeneic stem cell transplant: Where we now stand
4. Donor lymphocyte infusion induced molecular remission in relapse of acute myeloid leukaemia after allogeneic bone marrow transplantation
5. Donor lymphocyte infusion for the treatment of relapse after allogeneic hematopoietic stem cell transplantation
6. Adoptive immunotherapy: Insights from donor lymphocyte infusions
7. Adoptive immunotherapy with donor lymphocyte infusions after allogeneic HPC transplantation
8. Comparative outcomes of T-cell depleted and non-T-cell depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: Impact of donor lymphocyte infusion
9. Epstein-Barr (EBV) associated B-cell lymphoproliferative disease following HLA identical sibling marrow transplantation for aplastic anemia in a patient with an EBV seronegative donor
10. Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation
11. T-cell recovery following marrow transplant: Experience with delayed lymphocyte infusions to accelerate immune recovery or treat infectious problems
12. T-cell depleted bone marrow transplantation and delayed T cell add-back to control GVHD and conserve a graft vs leukemia effect
13. Regression of metastatic renal-cell carcinoma after non-myeloablative allogeneic peripheral blood stem cell transplantation
14. Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: Full donor T-cell chimerism precedes alloimmune responses
15. Transplant-lite: Induction of graft vs malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies
16. Donor lymphocyte infusion to eradicate recurrent host hematopoiesis after allogeneic BMT for sickle cell disease
17. In vitro collection and posttransfusion engraftment characteristics of MNCs obtained by using a new separator for autologous PBPC transplantation
18. Factors that influence lymphocyte yields in lymphocytapheresis
19. The ISHAGE guidelines for CD34+ cell determination by flow cytometry
20. Contact-dependent endothelial class II HLA gene activation is mediated by IFN γ-dependent and -independent mechanisms
21. "Panning" for lymphocytes. A method for cell separation
22. Induction of transporter associated with antigen processing by interferon-γ confers endothelial cell cytoprotection against natural killer-mediated lysis
23. Antigen-presenting function of human endothelial cells. Direct activation of resting CD8 T cells
24. Human vascular endothelial cells favor clonal expansion of unusual alloreactive CTL
25. Human vascular endothelial cells stimulate memory but not naive CD8+ T cells to differentiate into CTL retaining an early activation phenotype
26. Human endothelial cells induce and regulate cytolytic T cell differentiation
27. CARE-LASS (calcein-release-assay), an improved fluorescence-based test system to measure cytotoxic T lymphocyte activity
28. Large-scale culture and selective maturation of human Langerhans cells from granulocyte colony-stimulating factor-mobilized CD34+ progenitors
29. Determination of lymphocyte division by flow cytometry
30. Cytokines and endothelial cell biology
31. Phenotypic and functional characterization of lymphocytes that bind human microvascular endothelial cells in vitro
32. Biology and clinical relevance of human natural killer cells